Skip to main content
MediWound Ltd. logo

MediWound Ltd. — Investor Relations & Filings

Ticker · MDWD ISIN · IL0011316309 LEI · 549300LJKCS74GRYKF90 US Manufacturing
Open in API
Filings indexed 370 across all filing types
Latest filing 2023-11-21 Regulatory Filings
Country IL Israel
Listing US MDWD

About MediWound Ltd.

https://www.mediwound.com/

MediWound Ltd. is a fully integrated biopharmaceutical company that develops, manufactures, and commercializes enzymatic therapeutics for non-surgical tissue repair. The company's core technology focuses on next-generation treatments that selectively remove eschar (non-viable tissue) from severe burns and chronic wounds while preserving healthy tissue. This approach is designed to accelerate healing, improve patient outcomes, and lower overall healthcare costs. Its primary commercial product is a topical biologic for the debridement of severe thermal burns. MediWound maintains a research and development pipeline aimed at expanding its enzymatic platform to address additional unmet medical needs in wound care.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, MediWound Ltd. It includes a press release titled 'MediWound Reports Third Quarter 2023 Financial Results and Provides a Company Update' as Exhibit 99.1. The document length is 2503 characters, which is relatively short and primarily serves to report the issuance of the press release rather than containing detailed financial statements or analysis itself. According to the 'MENU VS MEAL' rule, such a document that attaches or references a report (press release) without containing the full report content should be classified as a Regulatory Filing (RNS). The document is not the full quarterly report (IR) but an announcement of the press release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-11-21 English
6-K
Board/Management Information Classification · 95% confidence The document is a Form 6-K filed by MediWound Ltd., which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. The content mainly announces the appointment of a new Chief Operating Officer and Chief Commercial Officer, as indicated by the attached press release (Exhibit 99.1). The document does not contain financial statements or detailed financial data, nor does it present an annual or interim report. It is primarily an announcement of a management change. According to the filing definitions, announcements of changes in senior management fall under Board/Management Information (MANG). The document length is 2555 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2023-11-21 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing, which is a report of a foreign private issuer submitted to the SEC. It includes an explanatory note about a press release issued by the company regarding a positive CHMP opinion recommending approval for a product. The document is short (2515 characters) and primarily serves to provide the press release as an exhibit. There are no financial statements or detailed financial data included. The document is essentially an announcement of a press release rather than a full report or detailed filing. According to the rules, such a document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-11-13 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, MediWound Ltd. It contains an explanatory note about a press release regarding additional funding from the U.S. Department of Defense. The document is short (2495 characters) and primarily serves to announce the press release, which is attached as Exhibit 99.1. There are no financial statements or detailed financial data included. The document is an announcement of information rather than a full report. According to the rules, such short filings that announce or attach other reports or press releases should be classified as Regulatory Filings (RNS).
2023-09-26 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by MediWound Ltd., which is a report of a foreign private issuer. The content includes an explanatory note about a press release regarding the U.S. commercial availability of a product, attached as Exhibit 99.1. The document is short (2496 characters) and primarily serves to announce the press release rather than provide detailed financial data or comprehensive reporting. Form 6-K filings are typically used for current reports by foreign private issuers and often contain press releases or other material information. Given the nature and length of the document, it fits best under Regulatory Filings (RNS) as it does not contain a full report or detailed financial statements but is a regulatory announcement filing with the SEC.
2023-09-21 English
SC 13D/A
Major Shareholding Notification
2023-09-01 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.